GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr | ₹2,327 Cr | ₹2,567 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹2,545 Cr |
Mar2023 | ₹2,447 Cr |
Mar2022 | ₹2,516 Cr |
Mar2021 | ₹2,327 Cr |
Mar2020 | ₹2,567 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹2,545 Cr | 3.99 | |
Mar2023 | ₹2,447 Cr | -2.73 | |
Mar2022 | ₹2,516 Cr | 8.11 | |
Mar2021 | ₹2,327 Cr | -9.34 | |
Mar2020 | ₹2,567 Cr | - |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹37,976.1 Cr | -3.6% | -6.4% | 30.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -3.6% |
-6.4% |
30.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses